These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 24021278)

  • 1. MD-2-dependent human Toll-like receptor 4 monoclonal antibodies detect extracellular association of Toll-like receptor 4 with extrinsic soluble MD-2 on the cell surface.
    Tsukamoto H; Ihara H; Ito R; Ukai I; Suzuki N; Kimoto M; Tomioka Y; Ikeda Y
    Biochem Biophys Res Commun; 2013 Oct; 440(1):31-6. PubMed ID: 24021278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple potential regulatory sites of TLR4 activation induced by LPS as revealed by novel inhibitory human TLR4 mAbs.
    Tsukamoto H; Fukudome K; Takao S; Tsuneyoshi N; Ihara H; Ikeda Y; Kimoto M
    Int Immunol; 2012 Aug; 24(8):495-506. PubMed ID: 22499954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable transduction of bovine TLR4 and bovine MD-2 into LPS-nonresponsive cells and soluble CD14 promote the ability to respond to LPS.
    Sauter KS; Brcic M; Franchini M; Jungi TW
    Vet Immunol Immunopathol; 2007 Jul; 118(1-2):92-104. PubMed ID: 17559944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide-binding protein-mediated Toll-like receptor 4 dimerization enables rapid signal transduction against lipopolysaccharide stimulation on membrane-associated CD14-expressing cells.
    Tsukamoto H; Fukudome K; Takao S; Tsuneyoshi N; Kimoto M
    Int Immunol; 2010 Apr; 22(4):271-80. PubMed ID: 20133493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lipopolysaccharide-recognition mechanism in cells expressing TLR4 and CD14 but lacking MD-2.
    Ohnishi T; Muroi M; Tanamoto K
    FEMS Immunol Med Microbiol; 2007 Oct; 51(1):84-91. PubMed ID: 17614960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycyrrhizin and isoliquiritigenin suppress the LPS sensor toll-like receptor 4/MD-2 complex signaling in a different manner.
    Honda H; Nagai Y; Matsunaga T; Saitoh S; Akashi-Takamura S; Hayashi H; Fujii I; Miyake K; Muraguchi A; Takatsu K
    J Leukoc Biol; 2012 Jun; 91(6):967-76. PubMed ID: 22422925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of monoclonal antibodies to human soluble MD-2 protein.
    Viriyakosol S; McCray PB; Ashbaugh ME; Chu J; Jia HP; Weiss J; Kirkland TN
    Hybridoma (Larchmt); 2006 Dec; 25(6):349-57. PubMed ID: 17203997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human TLR4 polymorphism D299G/T399I alters TLR4/MD-2 conformation and response to a weak ligand monophosphoryl lipid A.
    Yamakawa N; Ohto U; Akashi-Takamura S; Takahashi K; Saitoh S; Tanimura N; Suganami T; Ogawa Y; Shibata T; Shimizu T; Miyake K
    Int Immunol; 2013 Jan; 25(1):45-52. PubMed ID: 22962435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane-anchored CD14 is required for LPS-induced TLR4 endocytosis in TLR4/MD-2/CD14 overexpressing CHO cells.
    Shuto T; Kato K; Mori Y; Viriyakosol S; Oba M; Furuta T; Okiyoneda T; Arima H; Suico MA; Kai H
    Biochem Biophys Res Commun; 2005 Dec; 338(3):1402-9. PubMed ID: 16263085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CD14 antibody reduces LPS responsiveness via TLR4 internalization in human monocytes.
    Kim D; Kim JY
    Mol Immunol; 2014 Feb; 57(2):210-5. PubMed ID: 24172224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MD-2 expression is not required for cell surface targeting of Toll-like receptor 4 (TLR4).
    Visintin A; Halmen KA; Khan N; Monks BG; Golenbock DT; Lien E
    J Leukoc Biol; 2006 Dec; 80(6):1584-92. PubMed ID: 16946018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant soluble forms of extracellular TLR4 domain and MD-2 inhibit lipopolysaccharide binding on cell surface and dampen lipopolysaccharide-induced pulmonary inflammation in mice.
    Mitsuzawa H; Nishitani C; Hyakushima N; Shimizu T; Sano H; Matsushima N; Fukase K; Kuroki Y
    J Immunol; 2006 Dec; 177(11):8133-9. PubMed ID: 17114488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipopolysaccharide (LPS)-binding protein stimulates CD14-dependent Toll-like receptor 4 internalization and LPS-induced TBK1-IKKϵ-IRF3 axis activation.
    Tsukamoto H; Takeuchi S; Kubota K; Kobayashi Y; Kozakai S; Ukai I; Shichiku A; Okubo M; Numasaki M; Kanemitsu Y; Matsumoto Y; Nochi T; Watanabe K; Aso H; Tomioka Y
    J Biol Chem; 2018 Jun; 293(26):10186-10201. PubMed ID: 29760187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism regulating cell surface expression and activation of Toll-like receptor 4.
    Saitoh S; Miyake K
    Chem Rec; 2006; 6(6):311-9. PubMed ID: 17304555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LBP and CD14 secreted in tears by the lacrimal glands modulate the LPS response of corneal epithelial cells.
    Blais DR; Vascotto SG; Griffith M; Altosaar I
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4235-44. PubMed ID: 16249503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis of membrane and soluble forms of human MD-2.
    Viriyakosol S; Tobias PS; Kirkland TN
    J Biol Chem; 2006 Apr; 281(17):11955-64. PubMed ID: 16467306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran.
    Kim HM; Park BS; Kim JI; Kim SE; Lee J; Oh SC; Enkhbayar P; Matsushima N; Lee H; Yoo OJ; Lee JO
    Cell; 2007 Sep; 130(5):906-17. PubMed ID: 17803912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the lipopolysaccharide receptor complex (CD14, TLR4, MD-2) and toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection: relationship to tolerance.
    Calvano JE; Agnese DM; Um JY; Goshima M; Singhal R; Coyle SM; Reddell MT; Kumar A; Calvano SE; Lowry SF
    Shock; 2003 Nov; 20(5):415-9. PubMed ID: 14560104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate recognition of lipopolysaccharide by Toll-like receptor 4/MD-2 and RP105/MD-1.
    Miyake K; Ogata H; Nagai Y; Akashi S; Kimoto M
    J Endotoxin Res; 2000; 6(5):389-91. PubMed ID: 11521060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of TLR4/MD-2 complex in species-specific lipopolysaccharide-mimetic signal transduction by Taxol.
    Kawasaki K; Akashi S; Shimazu R; Yoshida T; Miyake K; Nishijima M
    J Endotoxin Res; 2001; 7(3):232-6. PubMed ID: 11581576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.